SCHEMBL2363701

SCHEMBL2363701

O=CN1CCOCC1c1cscn1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 1/20 0.33
ATR Q13535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30714973 0.74 PIK3C3 (0.41)
SCHEMBL29138859 0.73 CYP1A2 (0.33)
SCHEMBL23213435 0.71 PIK3C3 (0.41) PDE4DATR
SCHEMBL29651014 0.70
SCHEMBL29138900 0.69 HIF1A (0.39)
SCHEMBL29138869 0.69 HIF1A (0.39)
SCHEMBL17076741 0.69 PIK3C3 (0.33)
SCHEMBL29138887 0.68 SMN1; SMN2 (0.38) ATR
SCHEMBL29138874 0.68 SMN1; SMN2 (0.38) ATR
SCHEMBL29138795 0.68 ATM (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350077-A1 FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AstraZeneca AB (SE) 2011-08-03 EP disclosed